LAS VEGAS -- A controversy lingered under the circus tent that was Floyd Mayweather's May boxing bout against Manny Pacquiao.
That controversy was Mayweather's intravenous vitamin injection before the fight, which broke World Anti-Doping Agency guidelines, according to SB Nation's Thomas Hauser.
"In early March, USADA presented the Pacquiao camp with a contract that allowed the testing agency to grant a retroactive the****utic use exemption (TUE) to either fighter in the event that the fighter tested positive for a prohibited drug," Hauser wrote.
[Click Here To Read More]
That controversy was Mayweather's intravenous vitamin injection before the fight, which broke World Anti-Doping Agency guidelines, according to SB Nation's Thomas Hauser.
"In early March, USADA presented the Pacquiao camp with a contract that allowed the testing agency to grant a retroactive the****utic use exemption (TUE) to either fighter in the event that the fighter tested positive for a prohibited drug," Hauser wrote.
[Click Here To Read More]
Comment